Careers  |  Sign In  |  Register

Arthritis Drug Found to Treat Common Skin Condition

A recent case study from the Yale School of Medicine has found that tofacitinib, a drug frequently used to treat rheumatoid arthritis, has successfully treated a patient’s vitiligo reports CBS News. The condition is characterized by loss of pigmentation in the skin and after five months of treatment the majority of the white spots on the patient’s skin were eliminated without any major side effects. While this case study offers potential to other vitiligo patients, further study regarding the overall safety and efficacy is warranted.


Read the article published by CBS News.

Read the study published in JAMA Dermatology.